Clarity
Do they understand what you do?
15 could name what kind of product this is, unprompted.
https://speero.com/15 AI-simulated buyers
Your message needs work: they know what it is, who it's for, and why it's worth their time, but not why to pick you.
Do they understand what you do?
15 could name what kind of product this is, unprompted.
Can they tell what it solves, and who it's for?
10 could quickly tell what problem it solves and who it is for.
Do they actually want it?
11 would take a meeting to learn more.
Is there a reason to pick you over the alternatives?
0 could name a reason to pick you over a similar option.
Four separate measures, not stages: all 15 personas answered all four questions. Each square is one persona.
Two points describe the AI section as a disconnected list of tools rather than a coherent capability, with a tone closer to an internal wiki than a pitch to a director-level budget holder. Not one of the four layers, and it does not affect the scores above or the order to fix them in.
These are 15 simulated buyers. Want 15 real ones?
Test with humansThe first is on your weakest layer, the second on the next, the third on the layer the most buyers had a problem with. Each says what to change on the page and why, with one simulated answer behind it.
Why: XOS is the page's only claimed distinguishing asset and it is never explained, so it reads as a private label rather than a reason to choose Speero. In the hero subline, swap the parenthetical for a plain description of what the operating system consists of — the cadence, the roles, the artefacts a client receives in the first 90 days. A reader comparing three experimentation consultancies cannot pick one on an acronym.
5 of 15 raised this
“Every CRO/experimentation consultancy — Speero, CXL, Widerfunnel-types, the rest — bundles UX research, A/B testing, analytics audits and "strategic advisory" the same way”
Why: Dr. Squatch, Comcast, Freshworks and ClickUp span DTC, telecom and SaaS with no signal of company size or team shape, so a reader cannot tell which one resembles them. Add a short qualifier to each card — team size, program stage, industry — so relevance is decided at a glance rather than by clicking through five studies.
Why: The 5x figure closes the solution section with nothing behind it, so it reads as a slogan rather than a result. Either cite the client engagements it is averaged from with a before-and-after measure (tests shipped per month before, after, over what period), or replace it with a single verifiable client number already on the page, such as Freshworks reaching ten tests a month.
6 of 15 raised this
“A named regulated-industry client with real numbers — a bank or insurer, not Cisco or MongoDB, showing tests-shipped-per-quarter before and after, over some defined timeline, plus who internally signed off on the change.”
These landed. Keep the wording when you edit around it.
The problem statement about stalled, siloed experimentation is recognized as their own…
“"You're investing in growth, but progress is sluggish... you're not short on effort, you're short on traction." That's a real, recognizable pain, and it's clearly aimed at someone like me — enterprise CRO/growth leaders”
Named clients and case study specifics carry more credibility than the value claims…
“The client list (Cisco, MongoDB, Miro, ClickUp) is the only thing that gives it any credibility — logos I recognize matter more than the "5x your speed to impact" line, which is just a number with nothing behind it.”
Why: Every claim in "The Solution" — embedded framework, faster decisions, data over guesswork — is one any CRO or experimentation consultancy makes verbatim. Add a short block under the solution copy that names the specific difference: embedded operators sitting inside the client team versus project-based deliverables, engineering and analytics staffed alongside research rather than subcontracted, or a fixed timeframe to first shipped test. Pick the one that is actually true and state it as a…
5 of 15 raised this
“Every CRO/experimentation consultancy — Speero, CXL, Widerfunnel-types, the rest — bundles UX research, A/B testing, analytics audits and "strategic advisory" the same way”
Why: The strongest differentiating material on the page — Comcast, Freshworks, ClickUp, Dr. Squatch — sits below several screens of generic solution language. Lift one concrete result, such as Freshworks going from zero to ten tests a month, directly under the hero so the first proof a reader sees is something competitors cannot copy.
5 of 15 raised this
“Every CRO/experimentation consultancy — Speero, CXL, Widerfunnel-types, the rest — bundles UX research, A/B testing, analytics audits and "strategic advisory" the same way”
Why: "The Problem" is the best-performing copy on the page but the heading itself is anonymous. Retitle it to name who is feeling it — something like "If your testing program has stalled" — so scanning readers who own a siloed experimentation program know within two words that the section is about them.
Why: An unsourced 90% at the top of Data and Analytics casts doubt on every other number on the page. Add the sample beside it — how many audits, over what period, what counted as critically flawed — or drop the percentage and lead with what the audit finds and fixes instead.
6 of 15 raised this
“A named regulated-industry client with real numbers — a bank or insurer, not Cisco or MongoDB, showing tests-shipped-per-quarter before and after, over some defined timeline, plus who internally signed off on the change.”
No specific edits needed here — this layer held up.
Why: The problem copy speaks to mid-to-large product and marketing orgs, but nothing on the page says so, leaving regulated-industry visitors to expect financial services proof the case studies don't carry. Add a line near the hero naming the reader — experimentation, CRO and growth leaders running in-house testing programs at mid-to-large product organizations — so the right buyer self-identifies and the page stops implying a customer base it doesn't show.
2 of 15 raised this
“The AI section reads like a grab-bag of tool names (Replit, Cursor, VWO copilot, Claude+Figma MCP) rather than a coherent capability”
Why: Listing Replit, Claude and Figma MCP reads as an internal wiki entry. The tool names are credible as evidence of real practitioners, so keep them — but lead each with what it lets the client do (faster prototype-to-live test cycles, research synthesis in hours), and open the section with a single sentence a director-level budget holder can repeat to a CFO. The line "AI as infrastructure" needs to be cashed out into work delivered.
2 of 15 raised this
“The AI section reads like a grab-bag of tool names (Replit, Cursor, VWO copilot, Claude+Figma MCP) rather than a coherent capability”
Why: "Growth Engineering", "XOS", "DTA Workshop" and "high-velocity framework" all appear without definition, which shifts the register from a pitch to insider notes. Either give each a five-word gloss at first use or replace it with the plain description of the work.
2 of 15 raised this
“The AI section reads like a grab-bag of tool names (Replit, Cursor, VWO copilot, Claude+Figma MCP) rather than a coherent capability”
A deliberately adversarial read of the same answers. Each claim was checked back against what the personas said and dropped if nothing supported it.
The page wins attention with its problem framing and then loses the sale on proof.
Six respondents recognized the stalled, siloed experimentation problem as their own (theme 7), but six attacked the headline statistics as unsubstantiated with no methodology, sample or baseline (theme 1) and five could name nothing that distinguishes this from other CRO consultancies (theme 2). Recognition without differentiation hands the qualified reader straight to a competitor with the same diagnosis.
The only proof that works is the proof the page treats as secondary.
Three respondents rated the named client list and case study specifics explicitly above the abstract value claims (theme 5), while six rejected the headline stats outright (theme 1). The page leads with the material that fails and buries the material that lands.
XOS is a liability, not an asset.
Three respondents said XOS is named repeatedly but never defined and reads as internal jargon (theme 0), and five named the XOS framework as claimed but unproven against competitors (theme 2). The page's central branded concept consumes space, generates confusion, and differentiates nothing.
The page is written for the practitioner it employs, not the director it needs to convince.
Two respondents described the AI section as an internal tool list with the tone of a wiki rather than a pitch to a director-level budget holder (theme 3), and three flagged Growth Engineering and XOS as internal jargon obscuring positioning (theme 0). Nothing on the page translates capability into a budget case.
The buyer already knows the meeting condition and the page does not meet it.
Respondents stated that verified before/after benchmarks from similar-size companies would be the condition for taking a meeting (theme 1), and asked for a concrete example of XOS integrating with an existing marketing automation stack (theme 0). The page supplies neither, so the stated path to a conversation is closed.
The page courts regulated enterprise buyers it cannot serve with evidence.
Two respondents noted no financial services case studies despite regulated-industry targeting, said the messaging actually speaks to mid-to-large tech orgs, and called the 5x claim unsubstantiated specifically for the absence of a regulated case (theme 4). The targeting and the proof point in opposite directions.
Most respondents could not name anything distinguishing this from other CRO and…
5 of 15
“Every CRO/experimentation consultancy — Speero, CXL, Widerfunnel-types, the rest — bundles UX research, A/B testing, analytics audits and "strategic advisory" the same way”
“every experimentation consultancy I've talked to claims some version of "we integrate your stack and stop the silos."”
“branding a framework and listing tools you're experimenting with isn't a moat — every competitor in this space says "we're not just A/B testing, we're a system" and name-checks the same tool ecosystem”
The problem statement about stalled, siloed experimentation is recognized as their own…
6 of 15 · what worked
“"You're investing in growth, but progress is sluggish... you're not short on effort, you're short on traction." That's a real, recognizable pain, and it's clearly aimed at someone like me — enterprise CRO/growth leaders”
“"Problem" block spells it out in my own language: "Teams are siloed, timelines crawl... Attribution is a mess, accountability is thin... You're not short on effort, you're short on traction." That's exactly my situation”
“this isn't a tool, it's people you plug in — staff aug, retainer, or advisory — to fix a stalled testing program”
“It's meant for growth/marketing/product leaders whose testing programs have stalled”
“The Problem" section: "You're investing in growth, but progress is sluggish... you're not short on effort, you're short on traction." That's the real pitch, and it's aimed squarely at someone like me”
“It's fairly obvious what problem they're pitching to solve — "You're investing in growth, but progress is sluggish... you're not short on effort, you're short on traction" — that's basically my situation with test velocity, so it did land.”
The headline statistics are not believed because no methodology, sample or baseline is…
6 of 15
“A named regulated-industry client with real numbers — a bank or insurer, not Cisco or MongoDB, showing tests-shipped-per-quarter before and after, over some defined timeline, plus who internally signed off on the change.”
“"90% of analytics setups are critically flawed" and "5x your speed to impact" lines — no methodology, no sample, so I discount both”
“What I doubted immediately was the "90% of the analytics setups we've seen are critically flawed" stat — no source, no methodology, and that kind of unsupported superlative makes me trust the rest of the page less.”
“show me a case study — Miro, MongoDB, ClickUp, whoever — with actual before-and-after test velocity and business impact, not just a headline like "From Zero to 100 tests a year in just 6 months."”
“the one thing that moves this from "interesting logo list" to "worth my time" is a single documented before/after velocity number from a company our size and industry — not the "5x your speed to impact" line sitting there unsupported, but something like "went from X tests a quarter to Y tests a quarter over Z months, here's the methodology and here's who verified it."”
“the promise itself is fuzzy: "5x your speed to impact" with no baseline, an AI section that mixes live tools with stuff they're "exploring" with no line between them, so I can't tell what's proven versus aspirational”
XOS is repeated throughout but never defined
3 of 15
“a case study closer to our actual situation — mature marketing automation already in place, attribution gaps specifically”
Named clients and case study specifics carry more credibility than the value claims…
3 of 15 · what worked
“The client list (Cisco, MongoDB, Miro, ClickUp) is the only thing that gives it any credibility — logos I recognize matter more than the "5x your speed to impact" line, which is just a number with nothing behind it.”
“The case study list — Dr. Squatch, MongoDB, Miro, Cisco, ClickUp — is what actually convinces me this is real and not vaporware, because those are recognizable companies and the headlines are specific”
The offering is understood as embedded people, not software
2 of 15
“an agency, not a tool. They embed with your team to run A/B testing programs, UX research, and analytics audits”
“It's an experimentation/CRO consultancy and staff-aug agency — Speero — not a tool or platform. They sell people and process: research, A/B testing/CRO, and analytics engineering, wrapped in their own "XOS" operating system framework, plus advisory/training.”
The AI section reads as an internal tool list rather than a case for budget
2 of 15
“The AI section reads like a grab-bag of tool names (Replit, Cursor, VWO copilot, Claude+Figma MCP) rather than a coherent capability”
“Where it stopped feeling written for me was the AI section near the end — it turns into a tool inventory (Cursor, Replit, Claude, VWO copilot, paper.design) that reads like it's written for a practitioner audience or maybe their own team's internal wiki, not a director deciding where to spend budget.”
The page does not carry proof for the regulated-industry buyers it appears to court
2 of 15
“financial services nowhere obviously represented, which is itself a small flag for me”
“Right now it reads as built for scrappier product/marketing orgs, not a 2000+ person regulated company, so I'm not the audience they're proving this to.”
“A named regulated-industry client with real numbers — a bank or insurer, not Cisco or MongoDB, showing tests-shipped-per-quarter before and after, over some defined timeline, plus who internally signed off on the change.”
15 AI-simulated personas matched to your target market. Each answered independently, without seeing your goal, the scoring criteria, or each other’s answers. Attribution is role, industry and company size only.
Every answer on this page was written by an AI model role-playing a buyer profile, scored on Wynter’s B2B Message Layers framework. The personas were sampled in code across role, industry, company size and behavioral traits; the model wrote only the answers. Scores arrive through fixed verdict categories and the counts are computed in our own code, so no number here was written by a model.
The count is how many personas cleared the bar on each question. A yes can be unhesitating or come with reservations; the scorecard counts both as a yes, and this is the only place the difference is shown. Per layer:
These answers are AI-simulated and directional. Validate anything you’re betting on with real buyers, your ICPs.
A detailed, section-by-section message test report from verified B2B professionals who are actually in-market for what you sell.







